Fresenius Medical Care reserves €200 million in FCPA case
Germany-based Fresenius Medical Care, a provider of dialysis products and services, has set aside €200 million concerning its ongoing settlement negotiations with the U.S. government regarding potential violations of the Foreign Corrupt Practices Act.
THIS IS MEMBERS-ONLY CONTENT
You are not logged in and do not have access to members-only content.
If you are already a registered user or a member, SIGN IN now.
Related articles
-
BlogFresenius Medical Care reaches ‘agreement in principle’ in FCPA case
German healthcare company Fresenius Medical Care has reached an “agreement in principle” with U.S. authorities concerning an investigation into possible violations of the Foreign Corrupt Practices Act, booking charges of €224 million (U.S. $255 million) as of Dec. 31, 2018.
-
ArticleVenezuela military intervention highlights critical resources as a new compliance hotspot
President Donald Trump’s military intervention in Venezuela has sent a message across the world that he regards resources as critical to U.S. national security and will act to secure them. In Venezuela, this primarily means crude oil reserves. However, oil is not the only valuable resource in the U.S. sights.
-
OpinionExperts outline core skills compliance teams need to develop in 2026
Compliance teams will face a range of ongoing challenges in the coming year, as well as greater demands from boards and management for better, wider, and more real-time assurance on an increasing range of risk topics.